BSEInsider Trading / SAST1d ago · 24 Sept 2026, 10:54 am
Intimation of closure of trading window.
Aurobindo Pharma Ltd · 524804
✦ AI Summary
Aurobindo Pharma Ltd has announced the closure of its trading window for designated persons, including promoters, directors, and employees, from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half year ending on September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Ltd - 524804 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
2dbc7075-c7a9-4b92-b717-860bf02cc0a6.pdf
View document text
September 24, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Phiroz Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street,
MUMBAI -400 051 MUMBAI -400 001
Company Code No. AUROPHARMA Company Code No. 524804
Dear Sir / Madam,
Sub: Closure of Trading Window
This is to inform that as per the Company’s Internal Code of Conduct to Regulate, Monitor and Report Trading
by Designated Persons, the Trading Window for dealing in the securities of the Company would remain closed
for all designated persons including Promoters, Directors, Key Managerial Personnel, Employees, Connected
Persons and their immediate relatives with effect from October 1, 2026 till 48 hours after the declaration of
the Unaudited Financial Results of the Company for the second quarter and half year ending on September 30,
2026.
The date of the Board Meeting for declaration of the financial results of the Company for the second quarter
and half year ending on September 30, 2026, will be intimated in due course.
Please take the information on record.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B Adi Reddy
Company Secretary
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana., India. Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com